FDA Issues Draft Bioequivalence Guidances for 30 Drugs, Revises 17

Generic Line
A A
The FDA published new product-specific draft guidances for 30 active ingredients — including cancer therapies, asthma treatments, epinephrine auto-injectors and anti-infectives — outlining the agency’s preferred methods for supporting ANDA submissions.

To View This Article:

Login

Subscribe To Generic Line